FDA issued a Warning Letter to Columbia Presbyterian Medical Center on 12/22/2008 for a previous inspection.
483 Columbia Presbyterian Medical Center Aug 2012

483 Columbia Presbyterian Medical Center Aug 2012

Valentino Fiorella FDA, Charisse Green FDA, Philip Istafanos FDA, Paul Mouris FDA, Kazi Rafiquzzaman FDA, Kenneth Williams FDA$119.00 - Available Now

FDA investigators audited the Columbia Presbyterian Medical Center - New York, NY, United States facility and issued 3 inspectional observations (via FDA 483) on 10 Aug 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 10 Aug 2012
  • Location: New York, United States
  • FEI: 3001518810
Add To Cart